Immediate Impact

79 standout
Sub-graph 1 of 23

Citing Papers

Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial
2024 Standout
Aspirin for Metabolic Dysfunction–Associated Steatotic Liver Disease Without Cirrhosis
2024 Standout
3 intermediate papers

Works of Azmat Ali being referenced

Magnetic resonance imaging and spectroscopy for monitoring liver steatosis
2008

Author Peers

Author Last Decade Papers Cites
Azmat Ali 99 73 42 138 84 11 293
Valentina Cataldi 59 19 84 68 50 9 219
Norman Deane 17 44 26 60 46 10 289
Alicia Alvarez 18 44 82 62 37 11 279
Catarina Lindqvist 48 226 28 132 41 15 301
Mounika Angirekula 34 118 85 153 134 16 285
Yoshihito Goto 36 36 15 62 19 19 287
Carmen Serena Ricci 11 23 58 112 93 8 278
Luis Guevara 18 16 113 150 213 12 330
Seolhye Kim 18 12 39 83 29 15 305
I Roberts 28 30 66 94 69 12 332

All Works

Loading papers...

Rankless by CCL
2026